Fluorouracil and capecitabine: full DPYD sequencing to identify toxicity risk
Full DPYD sequencing may be considered to identify rare variants associated with DPD deficiency in patients receiving fluoropyrimidines. Cost-effectiveness depends on the healthcare system’s willingness to pay per additional QALY.
#fluorouracil #capecitabine canjhealthtechnol.ca